Viral Infections and Antiviral Therapies
Editat de Amal Kumar Dhara, Amit Kumar Nayaken Limba Engleză Paperback – 10 noi 2022
- Covers emerging and sexually transmitted viruses, including mode of transmission and pathophysiology of viral infections
- Describes antiviral agents and therapeutics for viruses such as rotaviruses, enteroviruses and coronaviruses
- Discusses strategies for the delivery of antiviral agents and vaccinations
Preț: 797.22 lei
Preț vechi: 1039.27 lei
-23% Nou
Puncte Express: 1196
Preț estimativ în valută:
152.59€ • 159.03$ • 127.02£
152.59€ • 159.03$ • 127.02£
Carte indisponibilă temporar
Doresc să fiu notificat când acest titlu va fi disponibil:
Se trimite...
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780323918145
ISBN-10: 032391814X
Pagini: 808
Ilustrații: 120 illustrations (50 in full color)
Dimensiuni: 191 x 235 mm
Editura: ELSEVIER SCIENCE
ISBN-10: 032391814X
Pagini: 808
Ilustrații: 120 illustrations (50 in full color)
Dimensiuni: 191 x 235 mm
Editura: ELSEVIER SCIENCE
Public țintă
Researchers and Scientists in virology and pharmaceutical sciences; Biomedical and pharmaceutical academia and professionals in the industries; Regulatory scientists in medicine, biomedicine, pharmaceutics, biotechnology, biology, microbiology; Graduate students and post docs with relevant background in virology and pharmacology.Cuprins
Section I: Introduction 1. Introduction to antiviral therapy
Section II: Viral infections and transmission 2. Emerging viral diseases 3. Evolution and transmission of viruses 4. Mode of viral infections and transmissions 5. Transmission and Intervention Dynamics of SARS-CoV-2 6. Sexually transmitted viral infections 7. Testing of viral infections 8. Electron microscopic methods for virus diagnosis
Section III: Antiviral agents and therapeutics 9. Virotherapy 10. Challenges in designing antiviral agents 11. Anti-influenza agents 12. Anti-herpes virus agents 13. Antiretroviral Therapies 14. Rotavirus and anti-rotaviral agents: Trends and advances 15. Current therapeutic strategies and novel antiviral compounds for the treatment of non-polio enteroviruses 16. Antiviral agents against flaviviruses 17. Pathophysiology of HIV and strategies to eliminate AIDS as a public health threat 18. Herbal drugs to combat viruses 19. Strategies for delivery of antiviral agents 20. Nanovesicles for delivery of antiviral agents 21. Antiviral biomaterials 22. Antiviral biomolecules from marine inhabitantsBalasubramanian 23. Plant polysaccharides as antiviral agents 24. Antiviral peptides against dengue virus 25. mRNA vaccines for COVID-19 26. Immunotherapy as an emerging and promising tool against viral infections 27. Role of nutraceuticals as immunomodulators to combat viruses
Section IV: Others 28. In vitro and in vivo approaches for evaluating antiviral efficacy 29. Clinical trials and regulatory considerations of antiviral agents 30. Future perspectives of antiviral therapy
Section II: Viral infections and transmission 2. Emerging viral diseases 3. Evolution and transmission of viruses 4. Mode of viral infections and transmissions 5. Transmission and Intervention Dynamics of SARS-CoV-2 6. Sexually transmitted viral infections 7. Testing of viral infections 8. Electron microscopic methods for virus diagnosis
Section III: Antiviral agents and therapeutics 9. Virotherapy 10. Challenges in designing antiviral agents 11. Anti-influenza agents 12. Anti-herpes virus agents 13. Antiretroviral Therapies 14. Rotavirus and anti-rotaviral agents: Trends and advances 15. Current therapeutic strategies and novel antiviral compounds for the treatment of non-polio enteroviruses 16. Antiviral agents against flaviviruses 17. Pathophysiology of HIV and strategies to eliminate AIDS as a public health threat 18. Herbal drugs to combat viruses 19. Strategies for delivery of antiviral agents 20. Nanovesicles for delivery of antiviral agents 21. Antiviral biomaterials 22. Antiviral biomolecules from marine inhabitantsBalasubramanian 23. Plant polysaccharides as antiviral agents 24. Antiviral peptides against dengue virus 25. mRNA vaccines for COVID-19 26. Immunotherapy as an emerging and promising tool against viral infections 27. Role of nutraceuticals as immunomodulators to combat viruses
Section IV: Others 28. In vitro and in vivo approaches for evaluating antiviral efficacy 29. Clinical trials and regulatory considerations of antiviral agents 30. Future perspectives of antiviral therapy